Document Report Card

Basic Information

ID: ALA1275492

Journal: Antimicrob Agents Chemother

Title: In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.

Authors: Amsler KM, Davies TA, Shang W, Jacobs MR, Bush K.

Abstract: In phase 3 clinical trials for ceftobiprole treatment of complicated skin and skin structure infections, 1,219 gram-positive and 276 gram-negative aerobic baseline pathogens were identified. Ceftobiprole inhibited all staphylococcal isolates, including methicillin-resistant strains, at MICs of

CiteXplore: 18591277

DOI: 10.1128/aac.00336-08